 |
|
|
| |
Atherosclerotic cardiovascular disease risk in chronic hepatitis C patients with metabolic dysfunction-associated steatotic liver disease after viral eradication: a multi-center cohort study: MASLD impacts outcomes
|
| |
| |
EASL 2025 May 7-10 Amsterdam
Wan-Long Chuang1, Pei-Chien Tsai2, Jee-Fu Huang1, Ming-Lun Yeh3, Chung-Feng Huang1,
Chiayen Dai1, Ming-Lung Yu3
|
| |
|
|
|
|
|
